New drug prevents bacterial diseases in poultry


Rising demand for meat and eggs and a resultant turn towards intensive poultry production has in recent decades given rise to a number of health and environmental concerns that pose a challenge to the poultry industry.

Proteon Pharmaceuticals, a Poland-based innovative biotechnology company has pioneered a revolutionary new approach to support healthy growth of chicken and other livestock. The new approach provides a sustainable tool for bacterial disease prevention. It also supports healthier poultry birds with improved performance.

The revolutionary new approach to bacterial control uses naturally occurring microorganisms ‘bacteriophages’ to eliminate pathogenic bacteria without causing any harm to the microbiome or gut flora of the birds. By promoting health growth of birds, this significantly reduces the need for use of antibiotics. 

Vetphage Pharmaceuticals is a subsidiary Company of Proteon Pharmaceuticals SA. Vetphage handles all operations for the APAC region. As its MD, Dr Bhavsar is leading the movement #IndiaForHealthyChicken from the front.

The products containing a cocktail of bacteriophage are 100% natural and biodegradable. They are used as feed additives for poultry and aquaculture, while the company is developing further solutions for pig and cattle farming. They help to reduce pathogenic bacteria without side effects, without leaving any residue and without creating antibiotic resistant strains of bacteria.

Be the first to comment

Leave a Reply

Your email address will not be published.